Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial

Identifieur interne : 000077 ( PascalFrancis/Curation ); précédent : 000076; suivant : 000078

Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial

Auteurs : Greg Guest [États-Unis] ; Dominick Shattuck [États-Unis] ; Laura Johnson [États-Unis] ; Betty Akumatey [Ghana] ; Edith Essie Kekawo Clarke [Ghana] ; Pai-Lien Chen [États-Unis] ; Kathleen M. Macqueen [États-Unis]

Source :

RBID : Pascal:09-0059294

Descripteurs français

English descriptors

Abstract

Background: One of the concerns raised regarding the introduction of any new HIV-prevention measure, such as PrEP, is the potential for risk disinhibition or sexual risk compensation. The oral tenofovir HIV prevention trial has been the subject of international discussion in this regard. Methods: This article maps the changes in sexual risk behavior among women participating in the oral tenofovir HIV prevention trial in Ghana. Content-driven, thematic analysis was carried out on qualitative data obtained from in-depth interviews with study participants. Growth curve analysis was the primary method used to document trends over time in self-reported sexual behavior collected monthly. Results: Overall, the study found that sexual risk behavior did not increase during the trial. Number of sexual partners and rate of unprotected sex acts decreased across the 12-month period of study enrollment. Certain subgroups of women, however, exhibited different growth curves. Data indicate that the HIV prevention counseling associated with the trial was effective. Conclusions: Counseling during the trial was effective. Different types of counseling and messaging may be needed for different subgroups within a population. These findings also have implications for required sample sizes for future HIV prevention trials where seroconversion is the main outcome.
pA  
A01 01  1    @0 0148-5717
A02 01      @0 STRDDM
A03   1    @0 Sex. transm. dis.
A05       @2 35
A06       @2 12
A08 01  1  ENG  @1 Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial
A11 01  1    @1 GUEST (Greg)
A11 02  1    @1 SHATTUCK (Dominick)
A11 03  1    @1 JOHNSON (Laura)
A11 04  1    @1 AKUMATEY (Betty)
A11 05  1    @1 KEKAWO CLARKE (Edith Essie)
A11 06  1    @1 CHEN (Pai-Lien)
A11 07  1    @1 MACQUEEN (Kathleen M.)
A14 01      @1 Division of Behavioral and Biomedical Research, Family Health International @2 North Carolina @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 7 aut.
A14 02      @1 Department of Sociology, University of Ghana @2 Legon @3 GHA @Z 4 aut.
A14 03      @1 Ghana Health Service, Ministry of Health @3 GHA @Z 5 aut.
A14 04      @1 Division of Biostatistics, Family Health International @2 North Carolina @3 USA @Z 6 aut.
A20       @1 1002-1008
A21       @1 2008
A23 01      @0 ENG
A43 01      @1 INIST @2 18921 @5 354000185008690090
A44       @0 0000 @1 © 2009 INIST-CNRS. All rights reserved.
A45       @0 27 ref.
A47 01  1    @0 09-0059294
A60       @1 P
A61       @0 A
A64 01  1    @0 Sexually transmitted diseases
A66 01      @0 USA
C01 01    ENG  @0 Background: One of the concerns raised regarding the introduction of any new HIV-prevention measure, such as PrEP, is the potential for risk disinhibition or sexual risk compensation. The oral tenofovir HIV prevention trial has been the subject of international discussion in this regard. Methods: This article maps the changes in sexual risk behavior among women participating in the oral tenofovir HIV prevention trial in Ghana. Content-driven, thematic analysis was carried out on qualitative data obtained from in-depth interviews with study participants. Growth curve analysis was the primary method used to document trends over time in self-reported sexual behavior collected monthly. Results: Overall, the study found that sexual risk behavior did not increase during the trial. Number of sexual partners and rate of unprotected sex acts decreased across the 12-month period of study enrollment. Certain subgroups of women, however, exhibited different growth curves. Data indicate that the HIV prevention counseling associated with the trial was effective. Conclusions: Counseling during the trial was effective. Different types of counseling and messaging may be needed for different subgroups within a population. These findings also have implications for required sample sizes for future HIV prevention trials where seroconversion is the main outcome.
C02 01  X    @0 002B05A03
C02 02  X    @0 002B30A03
C02 03  X    @0 002B05C02D
C03 01  X  FRE  @0 SIDA @5 01
C03 01  X  ENG  @0 AIDS @5 01
C03 01  X  SPA  @0 SIDA @5 01
C03 02  X  FRE  @0 Maladie sexuellement transmissible @5 02
C03 02  X  ENG  @0 Sexually transmitted disease @5 02
C03 02  X  SPA  @0 Enfermedad de transmisión sexual @5 02
C03 03  X  FRE  @0 Comportement sexuel @5 09
C03 03  X  ENG  @0 Sexual behavior @5 09
C03 03  X  SPA  @0 Conducta sexual @5 09
C03 04  X  FRE  @0 Prévention @5 10
C03 04  X  ENG  @0 Prevention @5 10
C03 04  X  SPA  @0 Prevención @5 10
C03 05  X  FRE  @0 Essai clinique @5 11
C03 05  X  ENG  @0 Clinical trial @5 11
C03 05  X  SPA  @0 Ensayo clínico @5 11
C07 01  X  FRE  @0 Virose
C07 01  X  ENG  @0 Viral disease
C07 01  X  SPA  @0 Virosis
C07 02  X  FRE  @0 Infection
C07 02  X  ENG  @0 Infection
C07 02  X  SPA  @0 Infección
C07 03  X  FRE  @0 Immunodéficit @5 37
C07 03  X  ENG  @0 Immune deficiency @5 37
C07 03  X  SPA  @0 Inmunodeficiencia @5 37
C07 04  X  FRE  @0 Immunopathologie @5 39
C07 04  X  ENG  @0 Immunopathology @5 39
C07 04  X  SPA  @0 Inmunopatología @5 39
N21       @1 040
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:09-0059294

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial</title>
<author>
<name sortKey="Guest, Greg" sort="Guest, Greg" uniqKey="Guest G" first="Greg" last="Guest">Greg Guest</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shattuck, Dominick" sort="Shattuck, Dominick" uniqKey="Shattuck D" first="Dominick" last="Shattuck">Dominick Shattuck</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Laura" sort="Johnson, Laura" uniqKey="Johnson L" first="Laura" last="Johnson">Laura Johnson</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Akumatey, Betty" sort="Akumatey, Betty" uniqKey="Akumatey B" first="Betty" last="Akumatey">Betty Akumatey</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Sociology, University of Ghana</s1>
<s2>Legon</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
</affiliation>
</author>
<author>
<name sortKey="Kekawo Clarke, Edith Essie" sort="Kekawo Clarke, Edith Essie" uniqKey="Kekawo Clarke E" first="Edith Essie" last="Kekawo Clarke">Edith Essie Kekawo Clarke</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Ghana Health Service, Ministry of Health</s1>
<s3>GHA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
</affiliation>
</author>
<author>
<name sortKey="Chen, Pai Lien" sort="Chen, Pai Lien" uniqKey="Chen P" first="Pai-Lien" last="Chen">Pai-Lien Chen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Division of Biostatistics, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Macqueen, Kathleen M" sort="Macqueen, Kathleen M" uniqKey="Macqueen K" first="Kathleen M." last="Macqueen">Kathleen M. Macqueen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">09-0059294</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 09-0059294 INIST</idno>
<idno type="RBID">Pascal:09-0059294</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000060</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000077</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial</title>
<author>
<name sortKey="Guest, Greg" sort="Guest, Greg" uniqKey="Guest G" first="Greg" last="Guest">Greg Guest</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shattuck, Dominick" sort="Shattuck, Dominick" uniqKey="Shattuck D" first="Dominick" last="Shattuck">Dominick Shattuck</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Laura" sort="Johnson, Laura" uniqKey="Johnson L" first="Laura" last="Johnson">Laura Johnson</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Akumatey, Betty" sort="Akumatey, Betty" uniqKey="Akumatey B" first="Betty" last="Akumatey">Betty Akumatey</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Sociology, University of Ghana</s1>
<s2>Legon</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
</affiliation>
</author>
<author>
<name sortKey="Kekawo Clarke, Edith Essie" sort="Kekawo Clarke, Edith Essie" uniqKey="Kekawo Clarke E" first="Edith Essie" last="Kekawo Clarke">Edith Essie Kekawo Clarke</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Ghana Health Service, Ministry of Health</s1>
<s3>GHA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
</affiliation>
</author>
<author>
<name sortKey="Chen, Pai Lien" sort="Chen, Pai Lien" uniqKey="Chen P" first="Pai-Lien" last="Chen">Pai-Lien Chen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Division of Biostatistics, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Macqueen, Kathleen M" sort="Macqueen, Kathleen M" uniqKey="Macqueen K" first="Kathleen M." last="Macqueen">Kathleen M. Macqueen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Sexually transmitted diseases</title>
<title level="j" type="abbreviated">Sex. transm. dis.</title>
<idno type="ISSN">0148-5717</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Sexually transmitted diseases</title>
<title level="j" type="abbreviated">Sex. transm. dis.</title>
<idno type="ISSN">0148-5717</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS</term>
<term>Clinical trial</term>
<term>Prevention</term>
<term>Sexual behavior</term>
<term>Sexually transmitted disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>SIDA</term>
<term>Maladie sexuellement transmissible</term>
<term>Comportement sexuel</term>
<term>Prévention</term>
<term>Essai clinique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Maladie sexuellement transmissible</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: One of the concerns raised regarding the introduction of any new HIV-prevention measure, such as PrEP, is the potential for risk disinhibition or sexual risk compensation. The oral tenofovir HIV prevention trial has been the subject of international discussion in this regard. Methods: This article maps the changes in sexual risk behavior among women participating in the oral tenofovir HIV prevention trial in Ghana. Content-driven, thematic analysis was carried out on qualitative data obtained from in-depth interviews with study participants. Growth curve analysis was the primary method used to document trends over time in self-reported sexual behavior collected monthly. Results: Overall, the study found that sexual risk behavior did not increase during the trial. Number of sexual partners and rate of unprotected sex acts decreased across the 12-month period of study enrollment. Certain subgroups of women, however, exhibited different growth curves. Data indicate that the HIV prevention counseling associated with the trial was effective. Conclusions: Counseling during the trial was effective. Different types of counseling and messaging may be needed for different subgroups within a population. These findings also have implications for required sample sizes for future HIV prevention trials where seroconversion is the main outcome.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0148-5717</s0>
</fA01>
<fA02 i1="01">
<s0>STRDDM</s0>
</fA02>
<fA03 i2="1">
<s0>Sex. transm. dis.</s0>
</fA03>
<fA05>
<s2>35</s2>
</fA05>
<fA06>
<s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>GUEST (Greg)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SHATTUCK (Dominick)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>JOHNSON (Laura)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>AKUMATEY (Betty)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>KEKAWO CLARKE (Edith Essie)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>CHEN (Pai-Lien)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>MACQUEEN (Kathleen M.)</s1>
</fA11>
<fA14 i1="01">
<s1>Division of Behavioral and Biomedical Research, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Sociology, University of Ghana</s1>
<s2>Legon</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Ghana Health Service, Ministry of Health</s1>
<s3>GHA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Division of Biostatistics, Family Health International</s1>
<s2>North Carolina</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20>
<s1>1002-1008</s1>
</fA20>
<fA21>
<s1>2008</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18921</s2>
<s5>354000185008690090</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>27 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>09-0059294</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Sexually transmitted diseases</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background: One of the concerns raised regarding the introduction of any new HIV-prevention measure, such as PrEP, is the potential for risk disinhibition or sexual risk compensation. The oral tenofovir HIV prevention trial has been the subject of international discussion in this regard. Methods: This article maps the changes in sexual risk behavior among women participating in the oral tenofovir HIV prevention trial in Ghana. Content-driven, thematic analysis was carried out on qualitative data obtained from in-depth interviews with study participants. Growth curve analysis was the primary method used to document trends over time in self-reported sexual behavior collected monthly. Results: Overall, the study found that sexual risk behavior did not increase during the trial. Number of sexual partners and rate of unprotected sex acts decreased across the 12-month period of study enrollment. Certain subgroups of women, however, exhibited different growth curves. Data indicate that the HIV prevention counseling associated with the trial was effective. Conclusions: Counseling during the trial was effective. Different types of counseling and messaging may be needed for different subgroups within a population. These findings also have implications for required sample sizes for future HIV prevention trials where seroconversion is the main outcome.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B05A03</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B30A03</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B05C02D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>SIDA</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>AIDS</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>SIDA</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Maladie sexuellement transmissible</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Sexually transmitted disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Enfermedad de transmisión sexual</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Comportement sexuel</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Sexual behavior</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Conducta sexual</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Prévention</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Prevention</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Prevención</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Essai clinique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Clinical trial</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Ensayo clínico</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Immunodéficit</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Immune deficiency</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Inmunodeficiencia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Immunopathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Immunopathology</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Inmunopatología</s0>
<s5>39</s5>
</fC07>
<fN21>
<s1>040</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000077 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000077 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:09-0059294
   |texte=   Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024